Lerner Center for Public Health Promotion (Center for Policy Research), Maxwell School of Citizenship and Public Affairs, Syracuse University, Syracuse, New York.
Am J Prev Med. 2018 May;54(5):611-619. doi: 10.1016/j.amepre.2018.01.040. Epub 2018 Mar 26.
Over the past 2 decades, drug-related deaths have grown to be a major U.S. public health problem. County-level differences in drug-related mortality rates are large. The relative contributions of social determinants of health to this variation, including the economic, social, and healthcare environments, are unknown.
Using data from the U.S. Centers for Disease Control and Prevention Multiple-Cause of Death Files (2006-2015, analyzed in 2017); U.S. Census Bureau; U.S. Department of Agriculture Economic Research Service; Agency for Healthcare Research and Quality; and Northeast Regional Center for Rural Development, this paper modeled associations between county-level drug-related mortality rates and economic, social, and healthcare environments. Spatial autoregressive models controlled for state fixed effects and county demographic characteristics.
The average county-level age-adjusted drug-related mortality rate was 16.6 deaths per 100,000 population (2006-2015), but there were substantial geographic disparities in rates. Controlling for county demographic characteristics, average mortality rates were significantly higher in counties with greater economic and family distress and in counties economically dependent on mining. Average mortality rates were significantly lower in counties with a larger presence of religious establishments, a greater percentage of recent in-migrants, and counties with economies reliant on public (government) sector employment. Healthcare supply factors did not contribute to between-county disparities in mortality rates.
Drug-related mortality rates are not randomly distributed across the U.S. Future research should consider the specific pathways through which economic, social, and healthcare environments are associated with drug-related mortality.
在过去的 20 年中,药物相关死亡已成为美国主要的公共卫生问题。县级药物相关死亡率的差异很大。健康的社会决定因素(包括经济、社会和医疗保健环境)对此变化的相对贡献尚不清楚。
本研究使用了美国疾病控制与预防中心多死因文件(2006-2015 年,于 2017 年进行分析)、美国人口普查局、美国农业部经济研究局、医疗保健研究与质量局以及东北区域农村发展中心的数据,建立了县级药物相关死亡率与经济、社会和医疗保健环境之间的关系模型。空间自回归模型控制了州固定效应和县级人口特征。
调整年龄后的县级平均药物相关死亡率为每 10 万人中有 16.6 人死亡(2006-2015 年),但死亡率存在显著的地域差异。在控制了县级人口特征后,经济和家庭困境较大的县以及经济上依赖矿业的县的平均死亡率显著较高。宗教机构较多、新移民比例较高以及经济依赖公共(政府)部门就业的县的平均死亡率显著较低。医疗保健供应因素并没有导致死亡率的县际差异。
药物相关死亡率在美国的分布并不随机。未来的研究应该考虑经济、社会和医疗保健环境与药物相关死亡率之间的具体关联途径。